PegBio - Crunchbase Company Profile & Funding

Q: Where is PegBio's headquarters?

PegBio is located in Suzhou, Jiangsu, China.

Q: Who invested in PegBio?

PegBio has 11 investors including Yingke Capital And Qianhai Fund of Funds.

Q: When was the last funding round for PegBio?

PegBio closed its last funding round on obfuscated from a Private Equity round.

Overview

PegBio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About PegBio

CB Rank

13256

PegBio is a Chinese innovative drug developer.

Founded

obfuscation

Public

Private Equity

Suzhou, Jiangsu, China

51-100

www.pegbio.com

Health Care

Pharmaceutical

Funding Rounds

Private Equity

OBF

obfuscation

Series E

OBF

obfuscation

Series D

OBF

obfuscation

Key People

Michael Xu: CEO

Details

Legal Name

PegBio Co., Ltd.

Also Known As

派格生物医药(苏州)有限公司, 派格医药, Paige Yiyao

Operating Status

Active

Stock Symbol

HKG:2565

Company Type

For Profit

Founders

Michael Xu

About the Company

Founded in 2008, Suzhou city-based PegBio is a bio-pharmaceutical company specializing in the development of innovative drugs to combat diabetes and obesity. Its key product PB-119, an agonist of glucagon-like peptide 1 (GLP-1), allows diabetes patients to take medicine once a week, instead of requiring daily injections.

Phone Number

+86 512-62956128

Contact Email

info@pegbio.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Vepainatide Injection (维派那肽注射液)

A long-acting GLP-1 receptor agonist injection developed for treating type 2 diabetes mellitus (T2DM).

GLP-1 Receptor Agonist Weight Loss Drug

A GLP-1 receptor agonist drug under investigation for obesity treatment to support weight reduction.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - PegBio	4	obfuscated obfuscation	Qianhai Fund of Funds, YF Capital, Yingke Capital	Private Equity
obfuscated obfuscation	Private Equity Round - PegBio	4	obfuscated obfuscation	Qianhai Fund of Funds, YF Capital, Yingke Capital	Private Equity
obfuscated obfuscation	Private Equity Round - PegBio	4	obfuscated obfuscation	Qianhai Fund of Funds, YF Capital, Yingke Capital	Private Equity
obfuscated obfuscation	Private Equity Round - PegBio	4	obfuscated obfuscation	Qianhai Fund of Funds, YF Capital, Yingke Capital	Private Equity
obfuscated obfuscation	Private Equity Round - PegBio	4	obfuscated obfuscation	Qianhai Fund of Funds, YF Capital, Yingke Capital	Private Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - PegBio	4	obfuscated obfuscation	Qianhai Fund of Funds, YF Capital, Yingke Capital	Private Equity
obfuscated obfuscation	Private Equity Round - PegBio	4	obfuscated obfuscation	Qianhai Fund of Funds, YF Capital, Yingke Capital	Private Equity
obfuscated obfuscation	Private Equity Round - PegBio	4	obfuscated obfuscation	Qianhai Fund of Funds, YF Capital, Yingke Capital	Private Equity
obfuscated obfuscation	Private Equity Round - PegBio	4	obfuscated obfuscation	Qianhai Fund of Funds, YF Capital, Yingke Capital	Private Equity
obfuscated obfuscation	Private Equity Round - PegBio	4	obfuscated obfuscation	Qianhai Fund of Funds, YF Capital, Yingke Capital	Private Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Yingke Capital	Yes	Private Equity Round - PegBio	—
Yingke Capital	Yes	Private Equity Round - PegBio	—
Yingke Capital	Yes	Private Equity Round - PegBio	—
Yingke Capital	Yes	Private Equity Round - PegBio	—
Yingke Capital	Yes	Private Equity Round - PegBio	—